Catalog Number 256082 |
Device Problem
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
Patient Problems
No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/03/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
|
|
Event Description
|
It was reported while testing for sars cov-2 a false positive result was obtained.The sample was repeated on the veritor and pcr test method and the result was negative.The customer stated the patient tested was asymptomatic.This test is not intended for use on asymptomatic patients and was therefore used off label.The results were reported to the state health department.There was no report of patient impact.(b)(4).
|
|
Manufacturer Narrative
|
H.6.Investigation: this statement summarizes the investigation results regarding the complaint that alleges false positive results when using kit rapid detection of sars-cov-2 veritor (material#: 256082), batch number: 0245289.Bd quality performs a systematic approach to investigate false positive complaints.This approach involves review of manufacturing batch history records, testing of retention samples, and testing of customer returned samples, if applicable.Testing were performed on the batch number provided and no issue was found.The complaint was unable to be confirmed via the retained samples.A photo was provided.The complaint issue could not be confirmed via the photo.The root cause could not be identified.A trend was identified for false positive results.Based on the trend, capa#: 1878253 was initiated.There were no corrective actions taken at this time.
|
|
Event Description
|
It was reported while testing for sars cov-2 a false positive result was obtained.The sample was repeated on the veritor and pcr test method and the result was negative.The customer stated the patient tested was asymptomatic.This test is not intended for use on asymptomatic patients and was therefore used off label.The results were reported to the state health department.There was no report of patient impact.Eua: (b)(4).
|
|
Search Alerts/Recalls
|